Article

How Can Pharma Companies Join the Digital Therapeutics Revolution?

Guidehouse’s Maya Desai and Andrew Fraser address the various steps digital therapeutics companies should be considering as they build their launch playbooks beyond the traditional commercial activities.

By Maya Desai and Andrew Fraser, Guidehouse 

More and more companies are joining forces with software developers to create innovative products. But many are learning the hard way that making next-generation digital therapeutics isn’t as easy as signing a partnership agreement. Guidehouse’s Maya Desai and Andrew Fraser address the various steps digital therapeutics companies should be considering as they build their launch playbooks beyond the traditional commercial activities.

 Read the full article in PharmExec

Maya Desai, Director

Andrew Fraser, Associate Director

RELATED SERVICES
MORE ON THIS TOPIC

Let Us Guide You

Guidehouse is a global consultancy providing advisory, digital, and managed services to the commercial and public sectors. Purpose-built to serve the national security, financial services, healthcare, energy, and infrastructure industries, the firm collaborates with leaders to outwit complexity and achieve transformational changes that meaningfully shape the future.

Stay ahead of the curve with news, insights and updates from Guidehouse about issues relevant to your organization and its work.